157 related articles for article (PubMed ID: 11522028)
1. The effects of transdermal and oral estrogen/progesterone regimens on free and total protein S in postmenopausal women.
Marque V; Alhenc-Gelas M; Plu-Bureau G; Oger E; Scarabin PY
Thromb Haemost; 2001 Aug; 86(2):713-4. PubMed ID: 11522028
[No Abstract] [Full Text] [Related]
2. Differential effects of oral and transdermal estrogen/progesterone regimens on sensitivity to activated protein C among postmenopausal women: a randomized trial.
Oger E; Alhenc-Gelas M; Lacut K; Blouch MT; Roudaut N; Kerlan V; Collet M; Abgrall JF; Aiach M; Scarabin PY; Mottier D;
Arterioscler Thromb Vasc Biol; 2003 Sep; 23(9):1671-6. PubMed ID: 12869355
[TBL] [Abstract][Full Text] [Related]
3. Effects of transdermal and oral estrogen replacement on lipids and glucose metabolism in postmenopausal women with type 2 diabetes mellitus.
Araújo DA; Farias ML; Andrade AT
Climacteric; 2002 Sep; 5(3):286-92. PubMed ID: 12419087
[TBL] [Abstract][Full Text] [Related]
4. Effects of the route of oestrogen administration on IGF-1 and IGFBP-3 in healthy postmenopausal women: results from a randomized placebo-controlled study.
Sonnet E; Lacut K; Roudaut N; Mottier D; Kerlan V; Oger E
Clin Endocrinol (Oxf); 2007 May; 66(5):626-31. PubMed ID: 17492948
[TBL] [Abstract][Full Text] [Related]
5. Association of oral but not transdermal estrogen therapy with enhanced platelet reactivity in a subset of postmenopausal women.
Flaumenhaft R; Nachtigall M; Lowenstein J; Nachtigall L; Nachtigall R; Nachtigall L
Menopause; 2009; 16(2):407-12. PubMed ID: 18989235
[TBL] [Abstract][Full Text] [Related]
6. A randomized, open-label, crossover study comparing the effects of oral versus transdermal estrogen therapy on serum androgens, thyroid hormones, and adrenal hormones in naturally menopausal women.
Shifren JL; Desindes S; McIlwain M; Doros G; Mazer NA
Menopause; 2007; 14(6):985-94. PubMed ID: 17507833
[TBL] [Abstract][Full Text] [Related]
7. [The administration of hormonal replacement therapy].
Suhonen S
Duodecim; 1996; 112(12):1073-80. PubMed ID: 10593008
[No Abstract] [Full Text] [Related]
8. Comparison of effects of continuous combined transdermal with oral estrogen and oral progestogen replacement therapies on serum lipoproteins and compliance.
Erenus M; Karakoç B; Gürler A
Climacteric; 2001 Sep; 4(3):228-34. PubMed ID: 11588947
[TBL] [Abstract][Full Text] [Related]
9. The effects of hormone replacement therapy on sleep-disordered breathing in postmenopausal women: a pilot study.
Manber R; Kuo TF; Cataldo N; Colrain IM
Sleep; 2003 Mar; 26(2):163-8. PubMed ID: 12683475
[TBL] [Abstract][Full Text] [Related]
10. [A French exception. Transdermal postmenopausal hormone therapy].
Plu-Bureau G
Rev Prat; 2010 Oct; 60(8):1122-3, 1125-30. PubMed ID: 21197748
[TBL] [Abstract][Full Text] [Related]
11. Influence of modified transdermal hormone replacement therapy on the concentrations of hormones, growth factors, and bone mineral density in women with osteopenia.
Stanosz S; Zochowska E; Safranow K; Sieja K; Stanosz M
Metabolism; 2009 Jan; 58(1):1-7. PubMed ID: 19059524
[TBL] [Abstract][Full Text] [Related]
12. Tibolone, transdermal estradiol or oral estrogen-progestin therapies: effects on circulating allopregnanolone, cortisol and dehydroepiandrosterone levels.
Pluchino N; Genazzani AD; Bernardi F; Casarosa E; Pieri M; Palumbo M; Picciarelli G; Gabbanini M; Luisi M; Genazzani AR
Gynecol Endocrinol; 2005 Mar; 20(3):144-9. PubMed ID: 16019353
[TBL] [Abstract][Full Text] [Related]
13. Effect of oral and transdermal estrogen replacement therapy on hemostatic variables associated with venous thrombosis: a randomized, placebo-controlled study in postmenopausal women.
Post MS; Christella M; Thomassen LG; van der Mooren MJ; van Baal WM; Rosing J; Kenemans P; Stehouwer CD
Arterioscler Thromb Vasc Biol; 2003 Jun; 23(6):1116-21. PubMed ID: 12730085
[TBL] [Abstract][Full Text] [Related]
14. Effect of oral estrogen on substrate utilization in postmenopausal women.
Lwin R; Darnell B; Oster R; Lawrence J; Foster J; Azziz R; Gower BA
Fertil Steril; 2008 Oct; 90(4):1275-8. PubMed ID: 18001731
[TBL] [Abstract][Full Text] [Related]
15. Effects of nonoral estradiol-micronized progesterone or low-dose oral estradiol-drospirenone therapy on metabolic variables and markers of endothelial function in early postmenopause.
Casanova G; Radavelli S; Lhullier F; Spritzer PM
Fertil Steril; 2009 Aug; 92(2):605-12. PubMed ID: 18706557
[TBL] [Abstract][Full Text] [Related]
16. Bleeding profiles and effects on the endometrium for women using a novel combination of transdermal oestradiol and natural progesterone cream as part of a continuous combined hormone replacement regime.
Vashisht A; Wadsworth F; Carey A; Carey B; Studd J
BJOG; 2005 Oct; 112(10):1402-6. PubMed ID: 16167944
[TBL] [Abstract][Full Text] [Related]
17. [Hormone therapy and risk of venous thromboembolism: new insights from the ESTHER study].
Canonico M; Scarabin PY
Med Sci (Paris); 2008 Mar; 24(3):228-31. PubMed ID: 18334161
[No Abstract] [Full Text] [Related]
18. [Hormone therapy and risk for venous thromboembolism in postmenopausal women].
Lacut K; Oger E
Rev Prat; 2005 Feb; 55(4):389-92. PubMed ID: 15828617
[TBL] [Abstract][Full Text] [Related]
19. Effect of different hormonal replacement therapies on circulating allopregnanolone and dehydroepiandrosterone levels in postmenopausal women.
Bernardi F; Pieri M; Stomati M; Luisi S; Palumbo M; Pluchino N; Ceccarelli C; Genazzani AR
Gynecol Endocrinol; 2003 Feb; 17(1):65-77. PubMed ID: 12724021
[TBL] [Abstract][Full Text] [Related]
20. [Hormonal replacement therapy in women after surgery for thyroid cancer treated with suppressive doses of L-thyroxine].
Jastrzebska H; Gietka-Czernel M; Zgliczyński S
Wiad Lek; 2001; 54 Suppl 1():383-8. PubMed ID: 12182054
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
